Revenue and profit declined sharply year-over-year due to weak domestic demand, but overseas sales and cash flow remained robust. The company maintained a strong balance sheet, continued R&D investment, and executed strategic restructuring, while addressing legal and regulatory risks.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.